Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets.  Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.

Venture Capital

Epidarex Capital

Managing Partners

Kyparissia Sirinakis

A. Sinclair Dunlop

Lori Gough

Matthew Miessau

Bridget Harris

Megan MacDougall

Melissa Lezameta

Anthony Voveris

Mary Canning

Elizabeth Roper

Peter Finan

Terri Burke

Henning Steinhagen

Epidarex Capital's Leadership Team includes Amanda Crook and 10 others.

Leadership Team

Leadership Team

About

Team members